Pure red cell aplasia associated with concomitant use of mycophenolate mofetil and ribavirin in post-transplant recurrent hepatitis C [1]

Transplant International

Volumn 19, Issue 2, 2006, Pages 170-171

  Hodo, Yuji ^a   Tsuji, Hirokazu ^a   Mizukoshi, Eishiro ^a   Yamashita, Tatsuya ^a   Sakai, Akito ^a   Nakamoto, Yasunari ^a   Honda, Masao ^a   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RIBAVIRIN;

ADULT; ANAMNESIS; CASE REPORT; DISEASE ASSOCIATION; HEPATITIS C; HUMAN; LABORATORY TEST; LETTER; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RECURRENT DISEASE;

ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RECURRENCE; RED-CELL APLASIA, PURE; RIBAVIRIN;

EID: 33645371262     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2005.00242.x     Document Type: Letter

References (14)

1. Koch RO Graziadei IW Schulz F et al. Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction Transpl Int 2004 17 518
2. Roche B Samuel D. Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C Transpl Int 2005 17 759
3. Giostra E Kullak-Ublick GA Keller W et al. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation Transpl Int 2004 17 169
4. Fisch P Handgretinger R Schaefer HE. Pure red cell aplasia Br J Haematol 2000 111 1010
5. Dessypris EN. Pure red cell aplasia In Hoffman R Benz EJ Jr. Shattil SJ et al. eds Hematology: Basic Principles and Practice 3rd edn
6. Arbeiter K Greenbaum L Balzar E et al. Reproducible erythroid aplasia caused by mycophenolate mofetil Pediatr Nephrol 2000 14 195
7. Engelen W Verpooten GA Van der Planken M Helbert MF Bosmans JL De Broe ME. Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients Clin Nephrol 2003 60 119
8. Misra S Moore TB Ament ME Busuttil RW McDiarmid SV. Red cell aplasia in children on tacrolimus after liver transplantation Transplantation 1998 65 575
9. Tanaka N Ishida F Tanaka E. Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C N Engl J Med 2004 350 1264
10. Tomita N Motomura S Ishigatsubo Y. Interferon-alpha-induced pure red cell aplasia following chronic myelogenous leukemia Anticancer Drugs 2001 12 7
11. Glue P. The clinical pharmacology of ribavirin Semin Liver Dis 1999 19 Suppl. 1 17
12. Allison AC Eugui EM. Mycophenolate mofetil and its mechanisms of action Immunopharmacology 2000 47 85
13. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. US. Renal Transplant Mycophenolate Mofetil Study Group Transplantation 1995 60 225
14. Sintchak MD Nimmesgern E. The structure of inosine 5′-monophosphate dehydrogenase and the design of novel inhibitors Immunopharmacology 2000 47 163